Photon, an end-to-end prescription infrastructure company, has raised a $16 million Series A led by Healthier Capital, with participation from Notation, Flare Capital, and Evidenced. The funding will support expansion of the engineering and commercial teams, drive health system and platform integrations, and accelerate Photon’s mission to become the default infrastructure for modern prescribing and medication access.
Electronic prescribing transformed how doctors write prescriptions but created a new problem for patients: at the moment a prescription is written, patients are asked to choose a pharmacy on the spot with no pricing, no inventory information, and no sense of what is convenient or covered. The prescription is sent without the information needed to make a well-informed decision, setting off a downstream chain of friction, including unnecessary transfers, unanswered phone calls, abandoned fills, and administrative burden across the healthcare ecosystem.
Photon is rebuilding the prescription experience from the ground up as a full end-to-end platform, integrating at the point of prescribing to give patients the ability to make an informed choice before a prescription is ever sent. The platform combines proprietary digital prescribing and routing infrastructure, a network of pharmacy partners across retail and home delivery, and a consumer-facing marketplace that surfaces real-time price and stock information. AI is central to how Photon processes complex, fragmented data across pharmacy networks, benefit structures, and formularies in real time, translating it into actionable information for patients.
For health systems, the platform turns the prescribing moment into a patient engagement touchpoint rather than a handoff, giving in-house pharmacy teams real-time visibility into fill activity and enabling patient education about delivery options and pricing. Since its founding in 2021, Photon has helped millions of patients make more informed pharmacy decisions, growing from its roots in direct-to-consumer digital health into an expanding health system presence. The company’s last fundraise was $9 million in July 2024.
KEY QUOTES:
“We’re building prescription infrastructure for the AI era. We’re scaling at a critical juncture where healthcare SaaS and services are being disrupted by LLMs and agentic workflows, right as healthcare affordability and consumer demand for transparency reach a boiling point. We’re leveraging this technology to empower consumers, enable true price transparency, and push the pharmacy industry back toward an open marketplace.”
Otto Sipe, Founder and CEO, Photon
“We are delighted to partner with Photon to modernize the prescription process, delivering an improved experience for patients while reducing friction across the entire healthcare system.”
Amir Dan Rubin, Founder and Managing Partner, Healthier Capital
